Orthopedic Biomaerials Market Analysis, Size, Trends | South Korea | MedSuite

Orthopedic Biomaerials Market Analysis, Size, Trends | South Korea | MedSuite

0

Bone graft substitutes are designed to fill bone voids, which eliminates the need for autograft harvesting of the patient’s own bone. Viscosupplementation products are injected directly into the affected knee joint to relieve pain caused by osteoarthritis. Growth factors are naturally occurring molecules in the body that mediate various cellular functions.

  • Year: 2016
  • Scope: 2016-2026
  • Region: South Korea
  • Published Date: 02/04/2020
  • Pages: 274
  • Type: MedSuite

Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. In 2019, approximately 15% of South Koreans were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65. Growth of this population is expected to stimulate growth across all segments of the orthopedic biomaterials market.

While this report suite contains all data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the market research that you need. You can view all these included reports and segmentation here:

  • Procedure Numbers for Orthobiologics – MedPro: Using a number of databases, internal and external, we’re able to provide you with the total volume of orthopedic biomaterials procedures being performed for each of the markets mentioned in this suite of reports.
  • Bone Graft Substitutes Market – MedCore: Bone is a biologically active tissue and will regenerate whenever possible; however, there are instances where the damage is significant enough to warrant a scaffold to help rejoin the fissure or cavity. Bone grafting is a surgical procedure in which damaged bone is replaced with autograft tissue, allograft tissue or a bone graft substitute, which can be either synthetic or metal.
  • Hyaluronic Acid Viscosupplementation Market – MedCore: Hyaluronic acids (HAs) are naturally occurring biopolymer fluids found in the joints that help cushion them from wear. Sufferers of osteoarthritis are deficient in these fluids. First proposed by Balazs in 1993, viscosupplementation with intraarticular hyaluronic acid (HA) injections have emerged as a viable treatment modality for nonoperative care of symptomatic osteoarthritis. Viscosupplements are injectable products that come in three varieties of injection regimens: single-injection, three-injection amd five-injection HA cycles.

Report Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • Forecasts Until 2026, and Historical Data to 2016
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares for Each Segment
  • Recent Mergers & Acquisitions
  • Procedure Volumes
  • Disease Overviews and Demographic Information
  • Company Profiles, Product Portfolios for Top Competitors
  • Related Press Releases from Top Competitors

Orthobiologics Market Share Insights

In 2019, the leading competitor in the South Korean orthopedic biomaterials market was Cellumed, which was attributed to its leading position in the orthopedic bone graft substitute market. The company held the second-leading position in the allograft and DBM allograft markets. Cellumed’s portfolio includes an allograft product line and the Rafugen™ DBM allograft product line.

TABLE OF CONTENTS I
LIST OF FIGURES VIII
LIST OF CHARTS XV

EXECUTIVE SUMMARY 1


SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 3
MARKET TRENDS 5
MARKET DEVELOPMENTS 6
PROCEDURE NUMBERS 7
MARKETS INCLUDED 8
KEY REPORT UPDATES 10
VERSION HISTORY 10

RESEARCH METHODOLOGY 11


Step 1: Project Initiation & Team Selection 11
Step 2: Prepare Data Systems and Perform Secondary Research 14
Step 3: Preparation for Interviews & Questionnaire Design 16
Step 4: Performing Primary Research 17
Step 5: Research Analysis: Establishing Baseline Estimates 19
Step 6: Market Forecast and Analysis 20
Step 7: Identify Strategic Opportunities 22
Step 8: Final Review and Market Release 23
Step 9: Customer Feedback and Market Monitoring 24

PRODUCT ASSESSMENT 25


2.1 INTRODUCTION 25
2.2 PRODUCT PORTFOLIOS 25
2.2.1 Bone Graft Substitutes 26
2.2.2 Growth Factors 32
2.2.2.1 Other Products 35
2.2.3 Hyaluronic Acid Viscosupplementation (HAV) 37
2.3 REGULATORY ISSUES AND RECALLS 40
2.3.1 Bone Graft Substitutes 40
2.3.1.1 Allografts 40
2.3.1.1.1 MTF 40
2.3.1.2 DBM 40
2.3.1.2.1 AlloSource 40
2.3.1.2.2 SeaSpine 41
2.3.1.2.3 RTI Surgical 41
2.3.1.3 Synthetics 41
2.3.1.3.1 Abyrx 41
2.3.1.3.2 Zimmer Biomet 42
2.3.2 Growth Factors 42
2.3.2.1.1 Medtronic 42
2.3.3 Hyaluronic Acid Viscosupplementation 43
2.3.3.1 Three-injection 43
2.3.3.1.1 Ferring Pharmaceuticals 43
2.4 CLINICAL TRIALS 44
2.4.1 Bone Graft Substitutes 44
2.4.1.1 Allografts 44
2.4.1.1.1 Providence Medical Technology 44
2.4.1.1.2 The University of Texas Health Science 44
2.4.1.1.3 University of Winchester 45
2.4.1.2 BDM 45
2.4.1.2.1 K2M 45
2.4.1.2.2 Zimmer Biomet 46
2.4.1.3 Synthetics 46
2.4.1.3.1 Baxter 46
2.4.1.3.2 Bonesupport 47
2.4.1.3.3 DePuy Synthes 47
2.4.1.3.4 NuVasive 49
2.4.1.3.5 RTI surgical 49
2.4.1.3.6 Sunstar GUIDOR 50
2.4.1.4 Other materials and comparison 51
2.4.1.4.1 Seoul National University Hospital. 51
2.4.1.4.2 Sewon Cellontech 51
2.4.1.4.3 SurgaColl Technologies Limited 52
2.4.1.4.4 University of Colorado 52
2.4.1.4.5 University of Padova 53
2.4.2 Growth Factors 53
2.4.2.1.1 Bioventus 53
2.4.2.1.2 Cerapedics 54
2.4.2.1.3 CGBio 54
2.4.2.1.4 Isto 55
2.4.2.1.5 Medtronic 55
2.4.2.1.6 NuVasive 57
2.4.2.1.7 Wright 57
2.4.2.1.8 Others 58
2.4.3 Hyaluronic Acid Viscosupplementation 59
2.4.3.1.1 Anika Therapeutics 59
2.4.3.1.2 Bioventus 60
2.4.3.1.3 Cairo University 61
2.4.3.1.4 Ferring Pharmaceuticals 61
2.4.3.1.5 Federal University of Minas Gerais 62
2.4.3.1.6 Fidia Pharma USA Inc. 62
2.4.3.1.7 Istituto Ortopedico Rizzoli 63
2.4.3.1.8 University Hospital 63
2.4.3.1.9 Universidade Nova de Lisboa 64

SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 65


3.1 INTRODUCTION 65
3.1.1 Bone Graft Substitutes 65
3.1.2 Growth Factors 65
3.1.3 Hyaluronic Acid (HA) Viscosupplementation 66
3.2 CURRENCY EXCHANGE RATE 67
3.3 MARKET OVERVIEW AND TREND ANALYSIS 68
3.4 DRIVERS AND LIMITERS 75
3.4.1 Market Drivers 75
3.4.2 Market Limiters 75
3.5 COMPETITIVE MARKET SHARE ANALYSIS 77
3.6 MERGERS AND ACQUISITIONS 82
3.7 COMPANY PROFILES 84
3.7.1 Anika Therapeutics 84
3.7.2 Bioventus 85
3.7.3 DePuy Synthes 86
3.7.4 Ferring Pharmaceuticals 87
3.7.5 Fidia Pharmaceuticals 88
3.7.6 Genzyme (Sanofi Group) 89
3.7.7 Harvest Technologies (Terumo BCT) 90
3.7.8 Integra LifeSciences 91
3.7.9 Medtronic 92
3.7.10 Musculoskeletal Transplant Foundation (MTF) 94
3.7.11 NuVasive 95
3.7.12 Orthofix 96
3.7.13 RTI Surgical 97
3.7.14 Stryker 98
3.7.15 Vericel Corporation (formerly Aastrom Bioscience) 99
3.7.16 Zimmer Biomet 100
3.8 SWOT ANALYSIS 102
3.8.1 Anika Therapeutics 102
3.8.2 Bioventus 104
3.8.3 DePuy Synthes 106
3.8.4 Ferring Pharmaceuticals 107
3.8.5 Fidia Pharmaceuticals 108
3.8.7 Harvest Technologies (Terumo BCT) 110
3.8.8 Integra LifeSciences 111
3.8.9 Medtronic 112
3.8.10 Musculoskeletal Transplant Foundation (MTF) 113
3.8.11 NuVasive 114
3.8.12 Orthofix 115
3.8.14 Stryker 117
3.8.15 Vericel Corporation (formerly Aastrom Bioscience) 118
3.8.16 Zimmer Biomet 119

PROCEDURE NUMBERS 121


4.1 INTRODUCTION 121
4.2 PROCEDURES 122
4.2.1 Orthopedic Biomaterial Procedures by Segment 122
4.2.2 Orthopedic Bone Grafting Procedures 124
4.2.2.1 Units per Procedure by Indication 124
4.2.2.2 Orthopedic Bone Grafting Procedures by Material 125
4.2.2.2.1 Autograft Procedures by Indication 127
4.2.2.2.2 Allograft Procedures by Indication 130
4.2.2.2.3 DBM Procedures by Indication 133
4.2.2.2.4 Synthetic Procedures by Indication 136
4.2.2.3 Orthopedic Bone Grafting Procedures by Indication 139
4.2.3 Hyaluronic Acid Viscosupplementation Procedures 142
4.2.3.1 Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle 142

ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET 144


5.1 INTRODUCTION 144
5.2 MARKET OVERVIEW 145
5.2.1 Orthopedic Bone Graft Substitute Market by Material 145
5.2.2 Orthopedic Bone Graft Substitute Market by Indication 150
5.3 MARKET ANALYSIS AND FORECAST 156
5.3.1 Total Orthopedic Bone Graft Substitute Market 156
5.3.2 Orthopedic Bone Graft Substitute Market by Material 158
5.3.2.1 Allograft Bone Graft Substitute Market 158
5.3.2.1.1 Allograft Bone Graft Substitute Market by Indication 161
5.3.2.2 Demineralized Bone Matrix Allograft Bone Graft Substitute Market 175
5.3.2.2.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication 178
5.3.2.3 Synthetic Bone Graft Substitute Market 192
5.3.2.3.1 Synthetic Bone Graft Substitute Market by Indication 195
5.3.3 Orthopedic Bone Graft Substitute Market by Indication 209
5.3.3.1 Spine Bone Graft Substitute Market 209
5.3.3.2 Cervical Spine Bone Graft Substitute Market 212
5.3.3.3 Thoracolumbar Spine Bone Graft Substitute Market 214
5.3.3.4 Trauma Bone Graft Substitute Market 216
5.3.3.5 Non-Union Trauma Bone Graft Substitute Market 219
5.3.3.6 Fresh Fracture Trauma Bone Graft Substitute Market 221
5.3.3.7 Large Joint Reconstruction Bone Graft Substitute Market 223
5.3.3.8 Hip Reconstruction Bone Graft Substitute Market 226
5.3.3.9 Knee Reconstruction Bone Graft Substitute Market 228
5.3.3.10 Foot Reconstruction Bone Graft Substitute Market 230
5.3.3.11 Craniomaxillofacial Bone Graft Substitute Market 233
5.3.3.12 Oncology Bone Graft Substitute Market 236
5.4 DRIVERS AND LIMITERS 239
5.4.1 Market Drivers 239
5.4.2 Market Limiters 239
5.5 COMPETITIVE MARKET SHARE ANALYSIS 241

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET 245


6.1 INTRODUCTION 245
6.1.1 Benefits of Viscosupplementation 246
6.1.2 Synovial Fluid 246
6.2 MARKET OVERVIEW 247
6.3 MARKET ANALYSIS AND FORECAST 253
6.3.1 Total Hyaluronic Acid Viscosupplementation Market 253
6.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market 256
6.3.3 Three-Injection Hyaluronic Acid Viscosupplementation Market 259
6.3.4 Five-Injection Hyaluronic Acid Viscosupplementation Market 262
6.4 DRIVERS AND LIMITERS 265
6.4.1 Market Drivers 265
6.4.2 Market Limiters 265
6.5 COMPETITIVE MARKET SHARE ANALYSIS 267

APPENDIX: ORTHOPEDIC GROWTH FACTOR MARKET 271


7.1 INTRODUCTION 271
7.1.1 BMP-2 (Cellumed, CG Bio) 272

ABBREVIATIONS 273



The "Japan Market Report Suite for Small Bone and Joint Orthopedic Devices Market Analysis, Size, Trends" includes analysis on the following companies currently active in this market:    

All Companies Analyzed in this Study

  • Cellumed
  • CG Bio
  • DePuy Synthes
  • Dong Kwang
  • DongKook
  • Hanmi
  • HansBiomed
  • JunYoung Medical
  • LG Chem
  • Medtronic
  • Sanofi
  • SeaSpine
  • Shin Poong
  • Unimed
  • Wright Medical
  • Zimmer Biomet

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology


close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link